Design of pyrimidine-based scaffolds as potential anticancer agents for human DHFR: three-dimensional quantitative structure–activity relationship by docking derived grid-independent descriptors
暂无分享,去创建一个
Jahan B. Ghasemi | Safoura Hariri | Farhad Shirini | Behnam Rasti | B. Rasti | F. Shirini | Safoura Hariri
[1] Fereshteh Shiri,et al. Identification of new potential HIV-1 reverse transcriptase inhibitors by QSAR modeling and structure-based virtual screening , 2018, Journal of receptor and signal transduction research.
[2] C. Nantasenamat,et al. Exploring the origin of phosphodiesterase inhibition via proteochemometric modeling , 2017 .
[3] Olivier Michielin,et al. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules , 2017, Scientific Reports.
[4] Haruki Nakamura,et al. Prediction of Synthetic Accessibility Based on Commercially Available Compound Databases , 2014, J. Chem. Inf. Model..
[5] L. Doyle,et al. Methotrexate cross-resistance in a mitoxantrone-selected multidrug-resistant MCF7 breast cancer cell line is attributable to enhanced energy-dependent drug efflux. , 2000, Cancer research.
[6] F. Sanz,et al. Anchor-GRIND: filling the gap between standard 3D QSAR and the GRid-INdependent descriptors. , 2005 .
[7] F. Momany,et al. Validation of the general purpose QUANTA ®3.2/CHARMm® force field , 1992 .
[8] Serdar Durdagi,et al. Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies. , 2010, Journal of molecular graphics & modelling.
[9] Suaib Luqman,et al. QSAR and Docking Studies on Capsazepine Derivatives for Immunomodulatory and Anti-Inflammatory Activity , 2014, PloS one.
[10] T. Efferth,et al. Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells , 2017, ACS omega.
[11] B. Kowalski,et al. Partial least-squares regression: a tutorial , 1986 .
[12] S. Wold,et al. PLS-regression: a basic tool of chemometrics , 2001 .
[13] S. Queener,et al. The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents. , 2008, Journal of medicinal chemistry.
[14] C. Jun,et al. Performance of some variable selection methods when multicollinearity is present , 2005 .
[15] C. Di Giacomo,et al. Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling. , 2004, Bioorganic & medicinal chemistry.
[16] Paola Gramatica,et al. Introduction General Considerations , 2022 .
[17] Xin Guo,et al. 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-d]pyrimidines as novel classical and nonclassical antifolates as potential dual thymidylate synthase and dihydrofolate reductase inhibitors. , 2010, Bioorganic & medicinal chemistry.
[18] Jahan B. Ghasemi,et al. 3D-QSAR and docking studies of the stability constants of different guest molecules with beta-cyclodextrin , 2014, Journal of Inclusion Phenomena and Macrocyclic Chemistry.
[19] N. Tawari,et al. A review of molecular modelling studies of dihydrofolate reductase inhibitors against opportunistic microorganisms and comprehensive evaluation of new models. , 2011, Current pharmaceutical design.
[20] Tingjun Hou,et al. Applications of Genetic Algorithms on the Structure-Activity Relationship Analysis of Some Cinnamamides , 1999, J. Chem. Inf. Comput. Sci..
[21] A. Vasudevan,et al. 2,4-diamino-5-deaza-6-substituted pyrido[2,3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases. , 1996, Journal of medicinal chemistry.
[22] S. Wold. Cross-Validatory Estimation of the Number of Components in Factor and Principal Components Models , 1978 .
[23] Bruce L. Bush,et al. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA , 1993, J. Comput. Aided Mol. Des..
[24] A. Anderson,et al. 2,4-Diamino-5-(2'-arylpropargyl)pyrimidine derivatives as new nonclassical antifolates for human dihydrofolate reductase inhibition. , 2011, Journal of molecular graphics & modelling.
[25] Manuel Pastor,et al. Development and Validation of AMANDA, a New Algorithm for Selecting Highly Relevant Regions in Molecular Interaction Fields , 2008, J. Chem. Inf. Model..
[26] I. Goldman,et al. Resistance to antifolates , 2003, Oncogene.
[27] Jun-qing Chen,et al. Design and synthesis of novel 4-benzothiazole amino quinazolines Dasatinib derivatives as potential anti-tumor agents. , 2013, European journal of medicinal chemistry.
[28] David Ryan Koes,et al. Pharmit: interactive exploration of chemical space , 2016, Nucleic Acids Res..
[29] W Pangborn,et al. Structure-based design and synthesis of lipophilic 2,4-diamino-6-substituted quinazolines and their evaluation as inhibitors of dihydrofolate reductases and potential antitumor agents. , 1998, Journal of medicinal chemistry.
[30] Paola Gramatica,et al. Principles of QSAR models validation: internal and external , 2007 .
[31] M. Vijjulatha,et al. Molecular Docking, 3D QSAR and Designing of New Quinazolinone Analogues as DHFR Inhibitors , 2011 .
[32] Johann Gasteiger,et al. Handbook of Chemoinformatics , 2003 .
[33] Jahan B Ghasemi,et al. Methods and applications of structure based pharmacophores in drug discovery. , 2013, Current topics in medicinal chemistry.
[34] R. Jackson,et al. Acquired methotrexate resistance in lymphoblasts resulting from altered kinetic properties of dihydrofoltate reductase. , 1977, European journal of cancer.
[35] Jahan B. Ghasemi,et al. Alignment independent 3D-QSAR, quantum calculations and molecular docking of Mer specific tyrosine kinase inhibitors as anticancer drugs , 2015, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[36] Hyunbo Cho,et al. Mining churning behaviors and developing retention strategies based on a partial least squares (PLS) model , 2011, Decis. Support Syst..
[37] Gabriele Cruciani,et al. Predictive models for hERG potassium channel blockers. , 2005, Bioorganic & medicinal chemistry letters.
[38] Vasant Ranade. Molecular Interaction Fields , 2006 .
[39] Feroz Khan,et al. In Silico Exploration of Anti‐Inflammatory Activity of Natural Coumarinolignoids , 2011, Chemical biology & drug design.
[40] Tina Talreja,et al. Design and synthesis of classical and nonclassical 6-arylthio-2,4-diamino-5-ethylpyrrolo[2,3-d]pyrimidines as antifolates. , 2007, Journal of medicinal chemistry.
[41] S. Pickett,et al. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.
[42] Jahan B. Ghasemi,et al. Docking, CoMFA and CoMSIA Studies of a Series of N-Benzoylated Phenoxazines and Phenothiazines Derivatives as Antiproliferative Agents , 2013 .
[43] Paola Gramatica,et al. The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models , 2003 .
[44] R. Jackson. Folate Antagonists as Therapeutic Agents, vol. 1: Biochemistry, Molecular Actions, and Synthetic Design; vol. 2: Pharmacology, Experimental and Clinical Therapeutics , 1985 .
[45] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[46] Paola Gramatica,et al. QSAR Modeling is not “Push a Button and Find a Correlation”: A Case Study of Toxicity of (Benzo‐)triazoles on Algae , 2012, Molecular informatics.
[47] L. Federico,et al. GRIND2-based 3D-QSAR and prediction of activity spectra for symmetrical bis-pyridinium salts with promastigote antileishmanial activity , 2017, Journal of biomolecular structure & dynamics.
[48] V. Cody,et al. Design, synthesis, and X-ray crystal structure of classical and nonclassical 2-amino-4-oxo-5-substituted-6-ethylthieno[2,3-d]pyrimidines as dual thymidylate synthase and dihydrofolate reductase inhibitors and as potential antitumor agents. , 2009, Journal of medicinal chemistry.
[49] H. Atreya,et al. Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer , 2018, Scientific Reports.
[50] Elisabetta Moroni,et al. 3D-QSAR Assisted Design, Synthesis and Evaluation of Novobiocin Analogues. , 2013, ACS medicinal chemistry letters.
[51] A. Kinsella,et al. Tumor resistance to antimetabolites. , 1998, General pharmacology.
[52] Y. Fall,et al. An application of two MIFs-based tools (Volsurf+ and Pentacle) to binary QSAR: the case of a palinurin-related data set of non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors. , 2011, European journal of medicinal chemistry.
[53] G. Caron,et al. GRIND-based 3D-QSAR to predict inhibitory activity for similar enzymes, OSC and SHC. , 2008, European journal of medicinal chemistry.
[54] Peter Ertl,et al. Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.
[55] L. A. Stone,et al. Computer Aided Design of Experiments , 1969 .
[56] Gabriele Cruciani,et al. Molecular interaction fields : applications in drug discovery and ADME prediction , 2005 .
[57] B. Rasti,et al. Proteochemometric modeling of the origin of thymidylate synthase inhibition , 2018, Chemical biology & drug design.
[58] B. Rasti,et al. New insights into the selective inhibition of the β-carbonic anhydrases of pathogenic bacteria Burkholderia pseudomallei and Francisella tularensis: a proteochemometrics study , 2018, Molecular Diversity.
[59] B. Rasti,et al. Probing the chemical interaction space governed by 4-aminosubstituted benzenesulfonamides and carbonic anhydrase isoforms , 2018, Research in pharmaceutical sciences.
[61] Jahan B. Ghasemi,et al. Docking and pharmacophore‐based alignment comparative molecular field analysis three‐dimensional quantitative structure–activity relationship analysis of dihydrofolate reductase inhibitors by linear and nonlinear calibration methods , 2013 .
[62] Matthew Clark,et al. The Probability of Chance Correlation Using Partial Least Squares (PLS) , 1993 .